BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Clinical trials for BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter radiation may be safer for recurrent prostate cancer
Disease control Recruiting nowThis study tests whether a precise, short-course radiation therapy (SBRT) works as well as a slightly longer radiation approach for prostate cancer that has come back after surgery or spread to a few spots. About 118 men will receive either SBRT or hypofractionated radiotherapy. …
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New trial aims to Fine-Tune prostate cancer treatment timing
Disease control Recruiting nowThis study looks at the best timing for combining targeted radiation (SBRT) with hormone therapy in men whose prostate cancer has returned and spread. It also tests if radiation to the pelvis can stop cancer from spreading further. About 532 men with recurrent, hormone-sensitive …
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
PET scans guide smarter prostate cancer treatment in major new trial
Disease control Recruiting nowThis study is for men whose prostate cancer has returned after surgery, shown by a rising PSA level. It tests whether adding a stronger drug combination (apalutamide plus abiraterone and prednisone) to standard radiation and hormone therapy can better control the cancer. For men …
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC
-
Home cancer care trial aims to ease burden for black men with prostate cancer
Symptom relief Recruiting nowThis study looks at whether giving cancer therapy at home instead of in a clinic is safe and improves the experience for Black men with advanced prostate cancer. About 38 participants will receive treatment both at home and in the clinic, then rate their satisfaction and report s…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 16, 2026 12:54 UTC